Department of Medical Physics, Apollo Proton Cancer Centre, 100 Feet Road Tharamani, Chennai, Tamil Nadu, India.
Department of Radiation Oncology, Apollo Proton Cancer Centre, 100 Feet Road Tharamani, Chennai, Tamil Nadu, India.
Br J Radiol. 2019 Oct;92(1102):20190382. doi: 10.1259/bjr.20190382. Epub 2019 Jul 23.
To measure leakage ambient dose equivalent H*(10) from stray secondary neutron and photon radiation around proton therapy (PT) facility and evaluate adequacy of shielding design.
H*(10) measurement were carried out at 149 locations around cyclotron vault (CV), beam transport system (BTS) and first treatment room (GTR3) of a multiroom PT facility using WENDI-II and SmartIon survey meter. Measurement were performed under extreme case scenarios wherein maximum secondary neutrons and photons were produced around CV, BTS and GTR3 by stopping 230MeV proton of 300nA on beam degrader, end of BTS and isocenter of GTR3. Weekly time average dose rate (TADR) were calculated from H*(10) value measured at selective hot spots by irradiating actual treatment plans of mix clinical sites.
The maximum total H*(10) were within 2 µSv/hr around CV, 5 µSv/hr around outer wall of BTS which increases up to 62 µSv/hr at the end of inside BTS corridor. Maximum H*(10) of 20.8 µSv/hr in treatment control console (P125), 23.4 µSv/hr behind the common wall between GTR3 and GTR2 (P132) and 25.7 µSv/hr above isocenter (P99) were observed around GTR3. Reduction of beam current from 6 to 3 nA and 1 nA at nozzle exit lead to decrease in total H*(10) at P125 from 20.8 to 11.35 and 4.62 µSv/hr. In comparison to extreme case scenario, H*(10) value at P125, P132 and P99 from clinically relevant irradiation parameters were reduce by a factor ranging from 8.6 for high range cube to 46.4 for brain clinical plan. The maximum weekly TADR per fraction was highest for large volume, sacral chordoma patient at 8.5 µSv/hr compare to 0.3 µSv/hr for brain patient. The calculated weekly TADR for 30 mix clinical cases and 15 fractions of 1 L cube resulted total weekly TADR of 83-84 µSv/hr at P125, P132 and P99. The maximum annual dose level at these hot spots were estimated at 4.37 mSv/Yr.
We have carried out an extensive measurement of H*(10) under different conditions. The shielding thickness of our PT facility is adequate to limit the dose to occupational worker and general public within the permissible stipulated limit. The data reported here can bridge the knowledge gap in ambient dose around PT facility and can also be used as a reference for any new and existing proton facility for intercomparison and validation.
First extensive investigation of neutron and photon H*(10) around PT facility and can bridge the knowledge gap on ambient dose.
测量质子治疗(PT)设施周围散射线中子和光子周围环境剂量当量 H*(10),并评估屏蔽设计的充分性。
使用 WENDI-II 和 SmartIon 测量仪,在回旋加速器拱顶(CV)、束传输系统(BTS)和第一治疗室(GTR3)周围的 149 个位置,在 CV、BTS 和 GTR3 周围最大程度地产生二次中子和光子的极端情况下进行 H*(10)测量,通过在束衰减器、BTS 末端和 GTR3 的等中心点上停止 230MeV 的 300nA 质子。通过辐照混合临床部位的实际治疗计划,从选择性热点测量的 H*(10)值计算每周时间平均剂量率(TADR)。
CV 周围的最大总 H*(10)在 2 µSv/hr 以内,BTS 外墙周围的最大 H*(10)在 5 µSv/hr 以内,BTS 内部走廊末端增加到 62 µSv/hr。在 GTR3 周围,观察到治疗控制台(P125)的最大 H*(10)为 20.8 µSv/hr,GTR3 和 GTR2 之间公共墙后面的最大 H*(10)为 23.4 µSv/hr(P132),等中心点上方的最大 H*(10)为 25.7 µSv/hr(P99)。将束流从 6 降低到 3 和 1 nA 在喷嘴出口处,P125 的总 H*(10)从 20.8 减少到 11.35 和 4.62 µSv/hr。与极端情况相比,临床相关照射参数下 P125、P132 和 P99 的 H*(10) 值降低了 8.6 倍(高范围立方)到 46.4 倍(脑临床计划)。对于大体积、骶骨脊索瘤患者,每个分数的最大每周 TADR 最高,为 8.5 µSv/hr,而脑患者为 0.3 µSv/hr。对于 30 个混合临床病例和 15 个 1 L 立方的分数,P125、P132 和 P99 的总每周 TADR 为 83-84 µSv/hr。这些热点的最大年剂量水平估计为 4.37 mSv/Yr。
我们在不同条件下进行了广泛的 H*(10)测量。我们的 PT 设施的屏蔽厚度足以将职业工人和公众的剂量限制在允许规定的限制内。这里报告的数据可以填补 PT 设施周围环境剂量的知识空白,也可以作为任何新的和现有的质子设施的参考,用于比较和验证。
首次对 PT 设施周围的中子和光子 H*(10)进行广泛调查,并可以填补环境剂量的知识空白。